<html>
<head>
<title>Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">生物编程工具包制造商Asimov从Andreessen Horowitz获得470万美元启动TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2017/12/19/bio-programming-toolkit-maker-asimov-launches-with-4-5m-from-andreessen-horowitz/">https://web.archive.org/web/https://techcrunch.com/2017/12/19/bio-programming-toolkit-maker-asimov-launches-with-4-5m-from-andreessen-horowitz/</a></blockquote><div><div class="article-content">
				<p id="speakable-summary" class="translated">生物技术是当今众多热门前沿技术之一，但有一点阻碍了它的发展，那就是与其他领域相比，它明显不太受传统计算技术的影响。从麻省理工学院的<a target="_blank" href="https://web.archive.org/web/20230206173632/http://news.mit.edu/2016/programming-language-living-cells-bacteria-0331" rel="noopener">研究所分离出来的一家名为</a><a target="_blank" href="https://web.archive.org/web/20230206173632/https://www.asimov.io/" rel="noopener"> Asimov </a>的新创公司，正致力于通过创造一套计算机辅助生物设计工具来弥合数字和生物之间的鸿沟。这是一个足够有先见之明的想法，它已经吸引了470万美元的种子资金。</p>
<p class="translated">阿西莫夫解决的问题是这样的。假设你是一家制药公司，试图制造一种微型生物相容机器，它可以容纳一定量的药物，并在感应到其他分子时释放药物。</p>
<p class="translated">为了做到这一点，你必须——嗯，除了大约一百万件其他事情之外——设计出相当于在分子尺度上工作的逻辑门和信号处理器。这是一个令人望而生畏的前景，因为创造分子机器是一个劳动密集型的过程，通常涉及创造给定结构的数千种变体，并反复测试它们以查看哪种有效。</p>
<p class="translated"><a target="_blank" href="https://web.archive.org/web/20230206173632/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png" rel="noopener"> <img decoding="async" class="aligncenter size-full wp-image-1579965" src="../Images/656a32ddb93d5281320b19b6a855b678.png" alt="" srcset="https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png 1500w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png?resize=150,17 150w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png?resize=300,34 300w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png?resize=768,88 768w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png?resize=680,78 680w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png?resize=1200,138 1200w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png?resize=50,6 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/asimovlogo.png"/> </a>阿西莫夫的创新是允许人们使用熟悉的工具和技术来创建如上的生物电路。事实上，他们会使用相同的工具，就好像他们要在硅和铜中构建类似的电路一样。</p>
<p class="translated">阿西莫夫的创始人——麻省理工学院的亚历克·尼尔森(Alec Nielsen)、拉贾·斯里尼瓦斯(Raja Srinivas)、克里斯·沃格特(Chris Voigt)和道格·登斯摩尔(Doug Densmore)——创造的技术将传统电路的逻辑和结构翻译成DNA链，可以引入生物体并在其中复制，在细胞内执行相同类型的计算(例如异或)。</p>
<p class="translated"><a target="_blank" href="https://web.archive.org/web/20230206173632/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png" rel="noopener"> <img decoding="async" loading="lazy" class="aligncenter size-full wp-image-1579964" src="../Images/04b5c16b592f23886aa821cf5cc40dc2.png" alt="" srcset="https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png 1000w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png?resize=150,70 150w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png?resize=300,140 300w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png?resize=768,358 768w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png?resize=680,317 680w, https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png?resize=50,23 50w" sizes="(max-width: 1000px) 100vw, 1000px" data-original-src="https://web.archive.org/web/20230206173632im_/https://techcrunch.com/wp-content/uploads/2017/12/main_image_v4-01.png"/> </a>内置的保护可以防止分子水平的错误，比如这个或那个结构彼此过于接近而导致的构象问题，因此，创作者声称该平台可以以90%的准确率告诉你你设计的电路是否可行。</p>
<p class="translated">一些技术细节可以在去年的麻省理工学院新闻稿<a target="_blank" href="https://web.archive.org/web/20230206173632/http://news.mit.edu/2016/programming-language-living-cells-bacteria-0331" rel="noopener">中找到，或者在尼尔森</a>最近的博客文章<a target="_blank" href="https://web.archive.org/web/20230206173632/https://www.asimov.io/blog/2017/12/19/the-circuitry-in-our-cells" rel="noopener">中找到。</a></p>
<p class="translated">在另一篇文章中，A16Z的普通合伙人维杰·潘德解释了他认为投资的充分理由:</p>
<blockquote><p class="translated">利用阿西莫夫的方法、高精度模拟和电路构建模块，我们可以大大加快生物电路的开发——降低其成本，并大大增加其先进性和复杂性。</p>
<p class="translated">我们仍然处于事物的“晶体管阶段”,所以还没有到现代微处理器的全部复杂性可以在单元电路中实现的地步。但是在许多最初的应用中，这项技术可以取得重大进展——就像早期的微处理器一样简单，却成为一项引人注目的技术。</p></blockquote>
<p class="translated">该公司在一份新闻稿中表示，这笔资金将使他们能够“迅速扩大规模，并与不同领域的客户合作。”</p>
<p class="translated">“随着生物技术稳步成为成熟的工程学科，我们努力让阿西莫夫成为设计生物计算的首选资源，”尼尔森写道。“我个人希望这项技术有一天能够提高我们治愈疾病的能力，推动清洁和可持续的制造业，并帮助养活不断增长的全球人口。”</p>
<p class="translated"><strong>更新</strong>:这篇文章最初说筹集的金额是450万美元，现在是470万美元。完全是我的错。</p>
			</div>

			</div>    
</body>
</html>